###begin article-title 0
Sarcoglycan Complex
###end article-title 0
###begin p 1
An American Heart Association Postdoctoral Fellow (0120483Z).
###end p 1
###begin p 2
###xml 516 521 <span type="species:ncbi:10090">mouse</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
The sarcoglycans are known as an integral subcomplex of the dystrophin glycoprotein complex, the function of which is best characterized in skeletal muscle in relation to muscular dystrophies. Here we demonstrate that the white adipocytes, which share a common precursor with the myocytes, express a cell-specific sarcoglycan complex containing beta-, delta-, and ϵ-sarcoglycan. In addition, the adipose sarcoglycan complex associates with sarcospan and laminin binding dystroglycan. Using multiple sarcoglycan null mouse models, we show that loss of alpha-sarcoglycan has no consequence on the expression of the adipocyte sarcoglycan complex. However, loss of beta- or delta-sarcoglycan leads to a concomitant loss of the sarcoglycan complex as well as sarcospan and a dramatic reduction in dystroglycan in adipocytes. We further demonstrate that beta-sarcoglycan null mice, which lack the sarcoglycan complex in adipose tissue and skeletal muscle, are glucose-intolerant and exhibit whole body insulin resistance specifically due to impaired insulin-stimulated glucose uptake in skeletal muscles. Thus, our data demonstrate a novel function of the sarcoglycan complex in whole body glucose homeostasis and skeletal muscle metabolism, suggesting that the impairment of the skeletal muscle metabolism influences the pathogenesis of muscular dystrophy.
###end p 2
###begin p 3
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN4"><sup>3</sup></xref>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 379 387 <span type="species:ncbi:9606">patients</span>
Muscle fat infiltration is recognized as a hallmark pathological feature in dystrophin glycoprotein complex (DGC)3-related muscular dystrophies (1) that include dystrophinopathies (2, 3) and sarcoglycanopathies (LGMD2C-F) (4). In agreement, magnetic resonance imaging measurements of fat infiltration allow accurate assessments of disease severity in Duchenne muscular dystrophy patients (3). Association of adipose tissue development with degenerative/regenerative or atrophic changes in skeletal muscle is also supported by the finding that adipogenesis-competent cells within the skeletal muscle are activated during muscle regeneration (5). However, the molecular mechanism(s) underlying muscle fatty metamorphosis remain unclear.
###end p 3
###begin p 4
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 268 268 268 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7"/>
###xml 268 268 268 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8"/>
###xml 268 268 268 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9"/>
###xml 268 268 268 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10"/>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 81 87 <span type="species:ncbi:9606">humans</span>
Ectopic fat deposition in skeletal muscles is primarily described in animals and humans with lipodystrophy and sarcopenia. In these conditions, the accumulation of lipids and adipocytes in skeletal muscle is often accompanied by hyperglycemia and insulin resistance (6-11), both of which are strong indicators of muscle metabolic defects (12, 13) and deregulated adipogenesis (14). Furthermore, both adipose-derived and muscle-derived stem cells differentiate into adipocytes upon exposure to high levels of glucose (15), linking impaired muscle metabolism with muscle fat deposition.
###end p 4
###begin p 5
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1127 1129 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1250 1257 1243 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1311 1313 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1304 1309 <span type="species:ncbi:10090">mouse</span>
###xml 1318 1323 <span type="species:ncbi:10090">mouse</span>
It is long held that the biogenesis of a basement membrane takes place in the earliest steps of adipogenesis and that extensive extracellular matrix (ECM) remodeling occurs throughout adipogenesis (16, 17). The concept that cell surface receptors play a role in the regulation of adipogenesis and thus may underlie metabolic disorders just recently emerged with a study of the integrin complexes (18). Given that the DGC in its capacity as an ECM receptor is critical for muscle integrity (19, 20) and that white adipocytes and skeletal muscle cells originate from the same mesenchymal precursor cells (21, 22), we set out to determine whether components of the skeletal muscle DGC are expressed in white adipocytes. Herein, we describe a unique adipose sarcoglycan (SG) complex that includes beta-, delta-, and ϵ-SG. This complex is tightly associated with sarcospan (Sspn) and dystroglycan (DG). Moreover, we show that DG functions as a novel ECM receptor in white adipocytes. Because adipose tissue and skeletal muscle play critical roles in the maintenance of normal glucose homeostasis and whole body insulin sensitivity (23), we examined the metabolic consequences of the SG complex disruption in both adipose tissue and skeletal muscle. Using in vivo approaches, we observed that the beta-SG null mouse (24), a mouse model of muscular dystrophy, is glucose-intolerant and exhibits whole body insulin resistance specifically due to impaired insulin-stimulated glucose uptake in skeletal muscle.
###end p 5
###begin title 6
EXPERIMENTAL PROCEDURES
###end title 6
###begin title 7

###end title 7
###begin title 8

###end title 8
###begin title 9
Animals
###end title 9
###begin p 10
Animal care and procedures were approved and performed in accordance with the standards set forth by the National Institutes of Health and the Animal Care Use and Review Committee at the University of Iowa.
###end p 10
###begin title 11
Biochemical Analysis
###end title 11
###begin p 12
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
White adipocytes were isolated from wild-type gonadal white adipose tissue (25). Total RNA extraction using RNA-STAT60TM (IsoTex Diagnostics Inc., Friendswood, TX) and preparation of total membrane extracts (26) were performed from isolated adipocytes. Sucrose gradient purification of the DGC components (27) was performed from isolated adipocytes and whole WT gonadal adipose tissue.
###end p 12
###begin title 13
Physiological Analysis
###end title 13
###begin p 14
###xml 110 111 110 111 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 632 633 632 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 793 794 793 794 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 798 800 798 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
Glucose tolerance tests (GTTs) were performed on 16-h fasted male mice following intraperitoneal injection of d-glucose (1 g/kg). Blood glucose was measured from tail vein using OneTouch Ultra test strips (LifeScan). Several measurements were done at each time point to ensure reproducibility, and the lowest value was used. Fasting insulin was quantified in serum using enzyme-linked immunosorbent assay (Millipore Corp.). Euglycemic-hyperinsulinemic (EU) clamps were conducted on male mice according to the slightly modified protocol (28). Basal rates of whole body glucose clearance were assessed using a continuous infusion of [3H]glucose for 2 h prior to the start of the clamp. Insulin was infused continuously at 4 milliunits/kg/min. Forty-five min before the end of the clamp, 2-deoxy-d-[1-14C]glucose was administrated as a bolus (10 muCi) to estimate insulin-stimulated glucose uptake in individual tissues.
###end p 14
###begin title 15
Statistics
###end title 15
###begin p 16
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
GTT data were analyzed with two-way repeated measures analysis of variance, and all pairwise multiple comparison procedures were done with the Bonferroni t test. Other data were analyzed with Student's unpaired t test.
###end p 16
###begin title 17
RESULTS
###end title 17
###begin p 18
###xml 337 343 330 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 343 344 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 610 616 595 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 616 617 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 702 708 687 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 708 709 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 919 920 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1170 1172 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1338 1341 1311 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myd</sup>
###xml 1351 1353 1324 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1415 1420 1388 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Large</italic>
###xml 1488 1489 1457 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1584 1586 1549 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1828 1833 1785 1790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Large</italic>
###xml 2278 2283 2219 2224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Large</italic>
###xml 2534 2539 2471 2476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Large</italic>
###xml 2598 2608 2531 2541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e. Pomt1</italic>
###xml 2610 2615 2543 2548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pomt2</italic>
###xml 2617 2624 2550 2557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PomGnt1</italic>
###xml 2630 2637 2563 2570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fukutin</italic>
###xml 2754 2756 2687 2689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1297 1302 <span type="species:ncbi:10090">mouse</span>
###xml 1327 1331 <span type="species:ncbi:10090">mice</span>
###xml 1362 1366 <span type="species:ncbi:10090">mice</span>
To determine whether known components of the DGC are expressed in white adipose tissue while ensuring that our results would not reflect contamination from other tissues, we chose freshly isolated white adipocytes as starting material. RT-PCR data revealed the presence of beta-, delta-, and ϵ-SG, Sspn and DG transcripts in adipocytes (Fig. 1A and ). The identity of these transcripts was confirmed by BLAST analysis. In contrast to skeletal muscle, there was a conspicuous absence of alpha-SG and gamma-SG transcript. The detection of a transcript correlated with the detection of the corresponding protein (Fig. 1B). Results were confirmed by immunofluorescence analysis of adipose tissue sections (Fig. 1C and data not shown). Of the known DGC proteins, DG is the focus of most research interest due to its widespread expression, association with the basal lamina, and the complex and heterogeneous tissue-specific O-glycosylation of its extracellular alpha-subunit. Post-translational modification of alpha-DG is critical for its interaction with a broad range of ECM proteins, and loss of this interaction is a common factor in the biogenesis of complex diseases (19). To better characterize the binding properties of alpha-DG in adipose tissue, we chose to make use of a well characterized mouse model, the myodystrophy mice (Largemyd or myd) (29). These mice have a spontaneous loss-of-function mutation in Large, which encodes a putative glycosyltransferase involved in alpha-DG O-glycosylation, leading to brain and skeletal muscle alpha-DG hypoglycosylation and pathology (30). We found adipocyte alpha-DG reactivity using antibodies directed against either the alpha-DG core (sheep5) or its sugar moieties (IIIH11), albeit at a lower relative molecular mass (120 kDa) than that in skeletal muscle (). The absence of Large led to a loss of alpha-DG glycosylated epitope, with preservation of the alpha-DG protein core in adipocytes (). Agrin and laminin-1 overlay experiments conclusively demonstrated that the adipose-specific glycosylation was sufficient for alpha-DG to function as an ECM ligand receptor (). As expected and consistent with the observations made in myd brain and skeletal muscle, laminin and agrin binding to alpha-DG were abolished in absence of Large (), with the level of expression of the SGs and Sspn being preserved (data not shown). These data demonstrate that Large-mediated post-translational processing of alpha-DG takes place in white adipocytes. In support of this conclusion, expression of Large and other alpha-DG post-translational processing enzymes, i.e. Pomt1, Pomt2, PomGnt1, and Fukutin, was observed in adipocytes by RT-PCR (), confirming a previous gene profiling study performed in white adipocytes (31).
###end p 18
###begin p 19
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of DGC components in white adipocytes.</bold>
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ad.</italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sk.M.</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 433 434 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 585 589 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-Gt</italic>
###xml 632 637 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-Rbt</italic>
###xml 688 697 686 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scale bar</italic>
###xml 579 583 <span type="species:ncbi:9925">goat</span>
###xml 624 630 <span type="species:ncbi:9986">rabbit</span>
Expression of DGC components in white adipocytes.A, transcripts of known DGC components were amplified from isolated adipocytes (Ad.) and skeletal muscle (Sk.M.) by RT-PCR in the presence (+) or absence (-) of reverse transcriptase (RT). B, expression of the corresponding proteins in total membrane fraction from white adipocytes (100 mug) and KCl-washed microsomes from skeletal muscle (50 mug), as determined by Western blotting. C, expression of DGC proteins in epididymal white adipose tissue, analyzed by confocal microscopy. Negative controls using cyanine 3-labeled anti-goat (A-Gt) and Alexa Fluor 555-labeled anti-rabbit (A-Rbt) were performed by omitting the primary antibody. Scale bar, 500 mum.
###end p 19
###begin p 20
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
To test whether the DGC components expressed in the white adipocytes associate in a fashion similar to that described for skeletal muscle (19, 20), we analyzed their co-fractionation on sucrose gradient (). We found that Sspn migrated in the denser gradient fractions, along with the beta-, delta-, and ϵ-SG and beta-DG. The tight association of these proteins upon solubilization indicates that these proteins are integral components of a multisubunit complex that via DG can function as a novel ECM receptor in the white adipocytes. Control experiments in differentiated 3T3-L1 cells supported this conclusion as well (data not shown).
###end p 20
###begin p 21
###xml 330 332 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 335 341 331 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 341 342 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 225 230 <span type="species:ncbi:10090">mouse</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
To determine whether the adipose SG complex functions as a single unit, we tested whether the loss of a single component will influence the expression of the others and impair alpha-DG function. We took advantage of existing mouse models of muscular dystrophy, each with a systemic genetic ablation of one skeletal DGC component (32). Fig. 2A shows the composition of the SG complex and its associated Sspn and DG in mdx and mdx3cv mice, utrophin (utrn), beta-SG, delta-SG, and alpha-SG null mice. As expected, loss of either full-length dystrophin (dys) or alpha-SG, whose expression are restricted to skeletal muscle, had no consequence on the expression of the SGs, Sspn, and DG at the adipocyte membrane nor on the ability of alpha-DG to bind laminin. The loss of all dys isoforms in mdx3cv mice or of utrn in the utrn null mice was accompanied by modest decreased expression of all the proteins tested and a reduced laminin binding to alpha-DG. Therefore, although one cannot rule out that a short dys isoform and utrophin could be expressed in the adipocytes, their expression does not appear to be critical for proper SG complex expression at the adipocyte plasma membrane. However, loss of either beta-SG or delta-SG led to a complete loss of the other SGs as well as Sspn. Moreover, only residual expression of the glycosylated form of alpha-DG could be detected, which correlated with weak residual laminin binding. Altogether, our data suggest that the adipose SG complex should be considered as a single unit that relies on all its individual components for full functionality.
###end p 21
###begin p 22
###xml 0 63 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-SG null mice are glucose-intolerant and insulin-resistant.</bold>
###xml 63 64 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 169 176 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lam o/l</italic>
###xml 307 308 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 376 377 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 406 407 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 431 432 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 441 444 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&#8211;E</italic>
###xml 543 546 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GIR</italic>
###xml 549 550 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 582 587 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sk.M.</italic>
###xml 615 618 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAT</italic>
###xml 621 622 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 739 740 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 743 757 735 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Filled columns</italic>
###xml 763 764 755 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 770 782 762 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">open columns</italic>
###xml 803 804 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 828 829 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
beta-SG null mice are glucose-intolerant and insulin-resistant.A, whole adipose tissue from various mouse models was analyzed by Western blotting and laminin-1 overlay (Lam o/l) after digitonin solubilization and glycoprotein enrichment. *, anti-core antibody sheep5; **, anti-carbohydrate antibody IIIH11. B, intraperitoneal GTTs performed on 3-4-month-old male mice. ●, WT, n = 14; o, beta-SG null mice, n = 7. Mean +/- S.E., *, p < 0.05. C-E, conscious EU clamps were performed on 3-4-month-old male mice. Whole body glucose infusion rate (GIR) (C) and glucose uptake in soleus (Sk.M.) and white adipose tissue (WAT) (D) were measured during clamp conditions. Hepatic glucose production was measured in both basal and clamp conditions (E). Filled columns, WT, n = 7; open columns, beta-SG null mice, n = 8. Mean +/- S.E., *, p < 0.05.
###end p 22
###begin p 23
###xml 359 366 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
Because both skeletal muscle and adipose tissue play important roles in glucose homeostasis, we took advantage of the beta-SG null mice due to the concomitant loss of expression of the entire adipose and skeletal SG complexes. Upon dissection, we observed that the beta-SG null mice had virtually no subcutaneous adipose tissue (data not shown). Furthermore, Table 1 demonstrates that the beta-SG null had a significant decrease of their visceral white adipose tissue mass (epididymal and retroperitoneal fat expressed as a percentage of total body mass) as compared with age-matched WT mice. Histological analysis of the white adipose tissue revealed conspicuous changes such as those that characterize lipodystrophy (). Specifically, unilocular cells were heterogeneous in size and shape; numerous small multilocular cells were present, and large blood vessels and fibrous strands coursed throughout the adipose tissue.
###end p 23
###begin p 24
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Organ weights expressed as a percentage of total weight</bold>
Organ weights expressed as a percentage of total weight
###end p 24
###begin p 25
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Organs were carefully dissected and weighed. Results are expressed as mean (S.E.). All experiments were performed in double-blind fashion. IBAT, intrascapular brown adipose tissue. *, p < 0.001.
###end p 25
###begin p 26
###xml 57 63 54 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 63 64 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 309 310 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 358 364 352 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 366 369 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&#8211;E</italic>
###xml 525 526 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 649 650 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 706 712 694 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 712 713 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1024 1025 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1036 1042 1021 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1042 1043 1027 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1112 1118 1097 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1118 1119 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1132 1138 1117 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1138 1139 1123 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
Functionally, beta-SG null mice were glucose-intolerant (Fig. 2B) and had a trend to have higher fasting insulin levels than their WT counterparts (data not shown), suggesting an alteration of their whole body insulin sensitivity. To address this last question, we performed conscious EU clamps coupled with [3H]glucose infusion in beta-SG null and WT mice (Fig. 2, C-E). EU clamps indicated that the glucose clearance was significantly diminished in the beta-SG null mice as compared with the WT controls (22% decrease with p = 0.029, data not shown), confirming the glucose tolerance test data. The whole body glucose infusion rate was 30% lower (p = 0.03) in the beta-SG null mice than in the controls (Fig. 2C), demonstrating that the null animals were insulin-resistant. Interestingly, insulin resistance was accompanied by decreased insulin sensitivity in skeletal muscle only (35% decrease in insulin-stimulated glucose uptake in skeletal muscle of beta-SG null mice as compared with that of WT age-matched controls, p = 0.016) (Fig. 2D). Insulin sensitivity remained normal in both white adipose tissue (Fig. 2D) and liver (Fig. 2E).
###end p 26
###begin title 27
DISCUSSION
###end title 27
###begin p 28
###xml 404 406 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 408 410 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 522 524 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 597 599 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 955 957 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
We have demonstrated here that white adipocytes express at their plasma membrane an SG complex unique to this cell type. It includes beta-, delta-, and ϵ-SG but lacks alpha- and gamma-SG as determined by RT-PCR and immunoblotting. Both beta-SG and delta-SG proteins can seed the formation of the SG complexes (alpha-betadeltagamma and ϵ-betadeltagamma) found in skeletal and smooth muscle, respectively (33, 34), and a recent model proposed that gamma-SG links the beta/delta-SG precomplex to alpha-SG in skeletal muscle (35). As zeta-SG, the latest SG identified is the closest gamma-SG homolog (36), it is possible that zeta-SG functionally replaces gamma-SG in white adipocytes. We also showed that Sspn co-purifies with the above SG complex and that its expression is gone in the adipose tissue of SG-null mice. It was previously suggested that the assembly of a complete SG complex was a prerequisite for proper expression of Sspn at the sarcolemma (37). Likewise, our data suggest that expression of Sspn at the adipocyte membrane is dependent on proper SG complex expression.
###end p 28
###begin p 29
###xml 38 40 38 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 155 155 155 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39"/>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 606 608 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 610 612 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 667 668 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 769 771 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 773 775 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 865 867 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 869 871 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
The role played by the ECM receptors (18) and the importance of the cell-cell and cell-matrix interactions in adipose tissue are just emerging concepts (38-40). Here, we found that decreased expression of DG and a loss of extracellular ligand binding to alpha-DG were associated with a loss of SG complex expression in white adipocytes. This suggests that the SG complex is necessary for functional DG expression as an ECM receptor at the adipocyte plasma membrane. The physiological characterization of beta-SG null mice suggests that these mice, primarily known as a genetic model of muscular dystrophy (24, 32), could also be a new genetic model of lipodystrophy (9). It is well established that adipose tissue serves as a crucial integrator of glucose homeostasis (12, 28) and that alterations of its physiology can have a wide range of metabolic consequences (41, 42). Thus, it is tempting to speculate that the alteration of the adipose SG complex could represent a new molecular mechanism underlying phenotypes of altered adiposity, abnormal fat distribution, and metabolic disorders, likely via an alteration of the cell-cell and/or cell-matrix interactions in adipose tissue. However, since the global ablation of beta-SG affects both skeletal muscle and adipocytes, future studies using tissue-specific knock-out animals will be necessary to specifically resolve the tissue-specific roles of the SG complex in glucose metabolism.
###end p 29
###begin p 30
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 223 223 223 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3"/>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 1093 1097 1090 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1164 1168 1157 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
###xml 1115 1119 <span type="species:ncbi:10090">mice</span>
###xml 1185 1189 <span type="species:ncbi:10090">mice</span>
###xml 1395 1403 <span type="species:ncbi:9606">patients</span>
###xml 1477 1485 <span type="species:ncbi:9606">patients</span>
Nevertheless, these findings raise novel questions that have important implications for clinical studies of muscular dystrophy. DGC-related muscular dystrophies are often accompanied by progressive muscle fat replacement (2-4), and the ECM imparts specific characteristics to each tissue. Thus, we speculate that the SG complex, along with Sspn and DG, plays a role in regulating the adipogenesis/myogenesis cell fate decisions potentially involved in the mechanism of muscle fat replacement. Furthermore, muscular dystrophies are complex diseases likely to involve more than the skeletal muscles (19). However, the efficiency of the therapeutic strategies are so far solely based on the recovery of the skeletal DGC and/or muscle strength (43, 44). Our data indicate that a cell-specific SG complex is expressed in the white adipocytes. Furthermore, we for the first time bring evidence of metabolic defects in the skeletal muscles and whole body of the beta-SG null mice. We speculate that the severity of the metabolic symptoms is likely to depend on whether the skeletal SG complex alone (i.e. in alpha-SG null mice) or both adipose and skeletal SG complexes (i.e. in beta-SG null mice) are disrupted and on the relative functional contribution of the primary missing protein. Although the association of metabolic defects with the progression of muscular dystrophy is not documented yet in patients, it is possible that the recovery of skeletal muscle function in treated patients might uncover new health problems due to defective SG complexes in non-muscle tissues, such as adipose tissue.
###end p 30
###begin title 31
Supplementary Material
###end title 31
###begin title 32
Supplemental Data
###end title 32
###begin p 33
This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR051199-01 through the NIAMS. This work was also supported by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant and by a grant from the Muscular Dystrophy Association.
###end p 33
###begin p 34
The on-line version of this article (available at ) contains ," , and .
###end p 34
###begin p 35
###xml 28 30 28 30 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">DG</term>
###xml 30 42 30 42 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="36">dystroglycan</p>
###xml 30 42 30 42 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="36">dystroglycan</p></def>
###xml 28 42 28 42 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">DG</term><def><p textid="36">dystroglycan</p></def></def-item>
###xml 42 45 42 45 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">DGC</term>
###xml 45 76 45 76 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">dystrophin glycoprotein complex</p>
###xml 45 76 45 76 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="37">dystrophin glycoprotein complex</p></def>
###xml 42 76 42 76 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">DGC</term><def><p textid="37">dystrophin glycoprotein complex</p></def></def-item>
###xml 76 78 76 78 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">SG</term>
###xml 78 89 78 89 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">sarcoglycan</p>
###xml 78 89 78 89 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="38">sarcoglycan</p></def>
###xml 76 89 76 89 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">SG</term><def><p textid="38">sarcoglycan</p></def></def-item>
###xml 89 93 89 93 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">Sspn</term>
###xml 93 102 93 102 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="39">sarcospan</p>
###xml 93 102 93 102 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="39">sarcospan</p></def>
###xml 89 102 89 102 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">Sspn</term><def><p textid="39">sarcospan</p></def></def-item>
###xml 102 104 102 104 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">RT</term>
###xml 104 125 104 125 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">reverse transcriptase</p>
###xml 104 125 104 125 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="40">reverse transcriptase</p></def>
###xml 102 125 102 125 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">RT</term><def><p textid="40">reverse transcriptase</p></def></def-item>
###xml 125 128 125 128 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">ECM</term>
###xml 128 148 128 148 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="41">extracellular matrix</p>
###xml 128 148 128 148 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="41">extracellular matrix</p></def>
###xml 125 148 125 148 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">ECM</term><def><p textid="41">extracellular matrix</p></def></def-item>
###xml 148 150 148 150 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">WT</term>
###xml 150 159 150 159 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">wild type</p>
###xml 150 159 150 159 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">wild type</p></def>
###xml 148 159 148 159 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">WT</term><def><p textid="42">wild type</p></def></def-item>
###xml 159 162 159 162 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">GTT</term>
###xml 162 184 162 184 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">glucose tolerance test</p>
###xml 162 184 162 184 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">glucose tolerance test</p></def>
###xml 159 184 159 184 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">GTT</term><def><p textid="43">glucose tolerance test</p></def></def-item>
###xml 184 186 184 186 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">EU</term>
###xml 186 213 186 213 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">euglycemic-hyperinsulinemic</p>
###xml 186 213 186 213 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">euglycemic-hyperinsulinemic</p></def>
###xml 184 213 184 213 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">EU</term><def><p textid="44">euglycemic-hyperinsulinemic</p></def></def-item>
###xml 213 217 213 217 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G10">utrn</term>
###xml 217 225 217 225 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">utrophin</p>
###xml 217 225 217 225 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45">utrophin</p></def>
###xml 213 225 213 225 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G10">utrn</term><def><p textid="45">utrophin</p></def></def-item>
###xml 225 228 225 228 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G11">dys</term>
###xml 228 239 228 239 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">dystrophin.</p>
###xml 228 239 228 239 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="46">dystrophin.</p></def>
###xml 225 239 225 239 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G11">dys</term><def><p textid="46">dystrophin.</p></def></def-item>
###xml 28 239 28 239 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">DG</term><def><p textid="36">dystroglycan</p></def></def-item><def-item><term id="G2">DGC</term><def><p textid="37">dystrophin glycoprotein complex</p></def></def-item><def-item><term id="G3">SG</term><def><p textid="38">sarcoglycan</p></def></def-item><def-item><term id="G4">Sspn</term><def><p textid="39">sarcospan</p></def></def-item><def-item><term id="G5">RT</term><def><p textid="40">reverse transcriptase</p></def></def-item><def-item><term id="G6">ECM</term><def><p textid="41">extracellular matrix</p></def></def-item><def-item><term id="G7">WT</term><def><p textid="42">wild type</p></def></def-item><def-item><term id="G8">GTT</term><def><p textid="43">glucose tolerance test</p></def></def-item><def-item><term id="G9">EU</term><def><p textid="44">euglycemic-hyperinsulinemic</p></def></def-item><def-item><term id="G10">utrn</term><def><p textid="45">utrophin</p></def></def-item><def-item><term id="G11">dys</term><def><p textid="46">dystrophin.</p></def></def-item></def-list>
The abbreviations used are: DGdystroglycanDGCdystrophin glycoprotein complexSGsarcoglycanSspnsarcospanRTreverse transcriptaseECMextracellular matrixWTwild typeGTTglucose tolerance testEUeuglycemic-hyperinsulinemicutrnutrophindysdystrophin.
###end p 35
###begin p 36
dystroglycan
###end p 36
###begin p 37
dystrophin glycoprotein complex
###end p 37
###begin p 38
sarcoglycan
###end p 38
###begin p 39
sarcospan
###end p 39
###begin p 40
reverse transcriptase
###end p 40
###begin p 41
extracellular matrix
###end p 41
###begin p 42
wild type
###end p 42
###begin p 43
glucose tolerance test
###end p 43
###begin p 44
euglycemic-hyperinsulinemic
###end p 44
###begin p 45
utrophin
###end p 45
###begin p 46
dystrophin.
###end p 46
###begin title 47
Acknowledgments
###end title 47
###begin p 48
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
We thank Sarah Anderson and Keith Garringer for maintaining the mouse colonies, Sally J. Prouty for technical assistance, and Campbell laboratory members for the critical reading of the manuscript. We also acknowledge The University of Iowa DNA Facility, which is supported in part by the Holden Comprehensive Cancer Center (HCCC), as well as the University of Iowa Hybridoma Facility.
###end p 48
###begin title 49
REFERENCES
###end title 49

